Creating a mobile app to help young adults quit using e-cigarettes
Development of a mobile health intervention for electronic cigarette use among young adults
['FUNDING_OTHER'] · UNIVERSITY OF CHICAGO · NIH-11082605
This study is creating a helpful text-message program for young adults who use e-cigarettes, aiming to support them in cutting down or quitting, and it will involve feedback from young people to make sure it meets their needs.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CHICAGO (nih funded) |
| Locations | 1 site (CHICAGO, UNITED STATES) |
| Trial ID | NIH-11082605 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a mobile health intervention specifically designed for young adults who use electronic nicotine delivery systems (e-cigarettes). The approach involves creating a text-message based program that provides support and resources to help users reduce their e-cigarette consumption and increase their chances of quitting. The research will include input from young adults through focus groups to ensure the intervention is relevant and effective, followed by a pilot study to test its feasibility and acceptability among participants.
Who could benefit from this research
Good fit: Ideal candidates for this research are young adults aged 12 to 20 who currently use e-cigarettes or are dual users of e-cigarettes and traditional cigarettes.
Not a fit: Patients who do not use e-cigarettes or are outside the age range of 12 to 20 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide young adults with effective tools to quit or reduce their e-cigarette use, potentially leading to better health outcomes.
How similar studies have performed: Other research has shown success with mobile health interventions for smoking cessation, indicating that this approach has potential for effectiveness.
Where this research is happening
CHICAGO, UNITED STATES
- UNIVERSITY OF CHICAGO — CHICAGO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BRETT, EMMA — UNIVERSITY OF CHICAGO
- Study coordinator: BRETT, EMMA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.